Shanghai Rendu Biotechnology Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Minghui Yu
Chief executive officer
CN¥1.1m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 9.4yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
What Shanghai Rendu Biotechnology Co., Ltd.'s (SHSE:688193) 26% Share Price Gain Is Not Telling You
Nov 05
A Look At The Intrinsic Value Of Shanghai Rendu Biotechnology Co., Ltd. (SHSE:688193)
Oct 16There Are Some Holes In Shanghai Rendu Biotechnology's (SHSE:688193) Solid Earnings Release
May 06We Like These Underlying Return On Capital Trends At Shanghai Rendu Biotechnology (SHSE:688193)
Apr 17What Shanghai Rendu Biotechnology Co., Ltd.'s (SHSE:688193) 29% Share Price Gain Is Not Telling You
Mar 08CEO
Minghui Yu (41 yo)
no data
Tenure
CN¥1,109,900
Compensation
Ms. Minghui Yu is GM & Director of Shanghai Rendu Biotechnology Co., Ltd.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | no data | CN¥1.11m | no data | |
| Accounting Supervisor | 9.4yrs | CN¥639.00k | no data | |
| Deputy GM & Director | 4.2yrs | CN¥704.40k | no data | |
| Senior Director of R&D | no data | CN¥753.00k | no data | |
| Deputy Director of Instrumentation | 10.3yrs | CN¥355.90k | no data |
9.4yrs
Average Tenure
46yo
Average Age
Experienced Management: 688193's management team is seasoned and experienced (9.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | no data | CN¥1.11m | no data | |
| Deputy GM & Director | 4.2yrs | CN¥704.40k | no data | |
| Independent Director | 4.3yrs | CN¥72.00k | no data | |
| Director | 1.3yrs | no data | no data | |
| Chairman of the Supervisory Board | 4.3yrs | no data | no data | |
| Independent Director | 4.3yrs | CN¥72.00k | no data | |
| Chairman of the Board | 17.5yrs | CN¥2.04m | 20.3% CN¥ 267.3m | |
| Supervisor | 4.3yrs | no data | no data | |
| Employee Representative Supervisor | 4.2yrs | no data | no data |
4.3yrs
Average Tenure
55yo
Average Age
Experienced Board: 688193's board of directors are considered experienced (4.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/08 00:54 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanghai Rendu Biotechnology Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|